BRIUX
Price
$16.91
Change
-$0.05 (-0.29%)
Updated
Oct 8 closing price
Net Assets
260.29M
CIRRX
Price
$17.51
Change
-$0.06 (-0.34%)
Updated
Oct 8 closing price
Net Assets
8.35B
Interact to see
Advertisement

BRIUX vs CIRRX

Header iconBRIUX vs CIRRX Comparison
Open Charts BRIUX vs CIRRXBanner chart's image
Baron Real Estate Income R6
Price$16.91
Change-$0.05 (-0.29%)
VolumeN/A
Net Assets260.29M
Cohen & Steers Real Estate Securities R
Price$17.51
Change-$0.06 (-0.34%)
VolumeN/A
Net Assets8.35B
BRIUX vs CIRRX Comparison Chart in %
View a ticker or compare two or three
VS
BRIUX vs. CIRRX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRIUX is a Hold and CIRRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIRRX has more cash in the bank: 8.35B vs. BRIUX (260M). CIRRX pays higher dividends than BRIUX: CIRRX (2.37) vs BRIUX (1.69). BRIUX was incepted earlier than CIRRX: BRIUX (8 years) vs CIRRX (11 years). CIRRX (1.25) is less costly to investors than BRIUX (0.90). BRIUX is a more actively managed with annual turnover of: 131.00 vs. CIRRX (35.00). CIRRX has a lower initial minimum investment than BRIUX: CIRRX (0) vs BRIUX (5000000). BRIUX annual gain was more profitable for investors over the last year : 5.45 vs. CIRRX (-2.00). BRIUX return over 5 years is better than : 41.64 vs. CIRRX (26.81).
BRIUXCIRRXBRIUX / CIRRX
Total Expense Ratio0.801.2564%
Annual Report Gross Expense Ratio0.901.2572%
Fund Existence8 years11 years-
Gain YTD2.2564.18854%
Front LoadN/AN/A-
Min. Initial Investment50000000-
Min. Initial Investment IRAN/AN/A-
Net Assets260M8.35B3%
Annual Yield % from dividends1.692.3771%
Returns for 1 year5.45-2.00-272%
Returns for 3 years45.4832.19141%
Returns for 5 years41.6426.81155%
Returns for 10 yearsN/A54.80-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NECCX14.820.02
+0.14%
Natixis US Equity Opportunities C
JFNSX70.08N/A
N/A
Janus Henderson Global Life Sciences S
VMCPX396.31N/A
N/A
Vanguard Mid Cap Index InstitutionalPlus
BGLAX14.91N/A
N/A
Brookfield Global Listed InfrastructureA
BRWRX27.40N/A
N/A
MFS Blended Research Growth Eq R1